Evaluation of the Antibacterial Activity of Quinoxaline Derivative Compound Against Methicillin-Resistant Staphylococcus aureus .
Abdelbagi ElfadilAhmad Mandeel AlzahraniHani AbdullahHamoud AlsamhanTurki S AbujamelHafsa Elawd AhmedAsif A Jiman-FataniPublished in: Infection and drug resistance (2023)
This experiment revealed that most MRSA isolates were associated with low MICs (1-4 μg/mL) for quinoxaline derivative compound. Overall, the susceptibility of the quinoxaline derivative compound signifies a promising efficacy against MRSA and may set a novel treatment approach.